Further Evidence that Alpha-Granule Components such as Platelet Factor 4 Are Involved in Platelet-IgG-Heparin Interactions during Heparin-Associated Thrombocytopenia

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Thrombosis and Haemostasis

• Publication date

  1993-08-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0038-1649587PMID 8236153
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insights into heparin‐induced thrombocytopenia

  1992cited by this paper
• Platelet Factor 4 Complexed to Heparin Is the Target for Antibodies Generated in Heparin-Induced Thrombocytopenia

  1992cited by this paper
• Increase in Fibrinolytic Activity after Erythropoietin Therapy

  1992cited by this paper
• Specific quantification of heparin-dependent antibodies for the diagnosis of heparin-associated thrombocytopenia using an enzyme-linked immunosorbent assay.

  1991cited by this paper
• Heparin‐induced thrombocytopenia: mechanism of interaction of the heparin‐dependent antibody with platelets

  1989cited by this paper
• Heparin-induced thrombocytopenia: effects of rabbit IgG, and its Fab and FC fragments on antibody-heparin-platelet interaction.

  1989cited by this paper
• Heparin-induced thrombocytopenia: laboratory studies.

  1988cited by this paper
• Improvement in the haemostatic defect of uraemia after treatment with recombinant human erythropoietin.

  1987cited by this paper
• Correction of the anemia of end-stage renal disease with recombinant human erythropoietin.

  1987cited by this paper
• Relationship between urinary fibrinogen degradation products and various types of chronic nephritis.

  1987cited by this paper
• Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis.

  1987cited by this paper
• Grey platelet syndrome: studies on platelet alpha‐granules, lysosomes and defective response to thrombin

  1987cited by this paper
• Evidence for the involvement of platelet glycoproteins other than GP Ib in heparin-associated thrombocytopenia and thrombosis.

  1987cited by this paper
• A diagnostic test for heparin-induced thrombocytopenia.

  1986cited by this paper
• Specific protein and glycoprotein deficiencies in platelets isolated from two patients with the gray platelet syndrome.

  1982cited by this paper
• The different glycoprotein abnormalities in thrombasthenic and Bernard-Soulier platelets.

  1979cited by this paper

• Decision Making And Problem Solving

  2014cites this paper
• Relationship between Platelet Aggregatory and Heparin-Induced Thrombocytopenia Type II

  2014cites this paper
• Frequency of heparin/platelet factor 4-dependent platelet antibodies in patients undergoing angioplasty and stenting for cardiovascular disease and their role for on-clopidogrel platelet reactivity

  2012cites this paper
• Anti-heparin-platelet factor 4 antibodies are associated with arterial and venous thrombosis in patients with maintenance haemodialysis

  2009cites this paper
• Mechanisms Involved in Heparin-Induced Thrombocytopenia and Associated Thrombosis

  2008cites this paper
• Role of Heparin-Dependent Antigens in Immune Heparin-Induced Thrombocytopenia

  2007cites this paper
• Anti-heparin-platelet factor 4 antibody is a risk factor for vascular access obstruction in patients undergoing hemodialysis.

  2003cites this paper
• Heparin‐induced thrombocytopenia

  2003cites this paper
• [Heparin induced thrombocytopenia].

  2003cites this paper
• A positive in vitro assay is required to diagnose heparin-induced thrombocytopenia.

  2003cites this paper
• Drug-induced and drug-dependent immune thrombocytopenias.

  2001cites this paper
• Heparin-induced thrombocytopenia.

  2001cites this paper
• Pathophysiology of Heparin-Induced Thrombocytopenia

  2000cites this paper
• Pathophysiology of heparin-induced thrombocytopenia. Clinical and diagnostic implications--a review.

  2000cites this paper
• Heparin-induced thrombocytopenia.

  1998cites this paper
• [Heparin-induced thrombopenia. Clinical manifestations and physiopathology].

  1998cites this paper
• Heparin-induced thrombocytopenia: diagnostic tests and biological mechanisms.

  1998cites this paper
• Les thrombopénies induites par l'héparine Physiopathologie et thérapeutique Conduite à tenir en chirurgie cardiaque

  1998cites this paper
• [Thrombopenia induced by heparin. From physiopathology to treatment].

  1997cites this paper
• Heparin-associated Thrombocytopenia and Thrombosis: Implications for Perioperative Management

  1997cites this paper
• A fatal low‐molecular‐weight heparin‐associated thrombocytopenia after hip surgery: possible usefulness of PF4‐heparin ELISA test

  1996cites this paper
• Importance of PF4 in heparin-induced thrombocytopenia: confirmation with gray platelets.

  1995cites this paper
• Heparin-associated thrombocytopenia: an update.

  1995cites this paper
• Antigen Generation in Heparin-Associated Thrombocytopenia: The Nonimmunologic Type and the Immunologic Type Are Closely Linked in Their Pathogenesis

  1995cites this paper
• Heparin-induced thrombocytopenia

  1995cites this paper
• ANNOTATION

  1944cites this paper